Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer
This study has been completed.
Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Aventis Pharmaceuticals
Information provided by:
Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00165464
First received: September 9, 2005
Last updated: April 24, 2009
Last verified: April 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2009 |
| Primary Completion Date: | March 2005 (Final data collection date for primary outcome measure) |